• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prp19促进肝癌细胞中p21依赖的衰老。

Prp19 Facilitated p21-Dependent Senescence of Hepatocellular Carcinoma Cells.

作者信息

Yin Jie, Zhang Guang-Cong, Fang Ying, Yu Xiang-Nan, Liu Tao-Tao, Dong Ling, Shen Xi-Zhong

机构信息

Department of Gastroenterology, Zhongshan Hospital of Fudan University, Shanghai, China.

Shanghai Institute of Liver Diseases, Shanghai, China.

出版信息

J Oncol. 2022 Mar 21;2022:5705896. doi: 10.1155/2022/5705896. eCollection 2022.

DOI:10.1155/2022/5705896
PMID:35356253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8959953/
Abstract

INTRODUCTION

Evidence suggests that the role of senescence in the development of cancer is context-dependent. An orthologue of human pre-mRNA processing factor 19 (Prp19) attenuates the senescence of human endothelial cells. Prp19 has been reported to be involved in the progression of hepatocellular carcinoma (HCC). This work aims to investigate the effect of Prp19 on the senescence of HCC.

MATERIALS AND METHODS

Senescence of L02 cells and HCC cells under different stimuli was detected through cell cycle analysis, SA--gal staining, and senescence associated secretory phenotype analysis. The relationship between Prp19 and senescence-related proteins was evaluated using real-time RT-PCR, western blot assay, and immunohistochemistry. Subcutaneous xenograft tumors in nude mice were used to evaluate the role of Prp19 on senescence . Data analysis was carried out using GraphPad Prism 6.

RESULTS

Prp19 facilitated the senescence of L02 cells and HCC cells under different stresses. Prp19 positively modulated p21 expression in the mRNA level. Downregulation of Prp19 promoted the growth of subcutaneous xenograft tumors generated by HCC cell lines.

CONCLUSIONS

Prp19 may promote senescence of HCC cells via regulating p21 expression.

摘要

引言

有证据表明衰老在癌症发展中的作用取决于具体情况。人类前体mRNA加工因子19(Prp19)的一个直系同源物可减弱人类内皮细胞的衰老。据报道,Prp19参与肝细胞癌(HCC)的进展。这项研究旨在探究Prp19对HCC细胞衰老的影响。

材料与方法

通过细胞周期分析、SA-β-半乳糖苷酶染色及衰老相关分泌表型分析,检测不同刺激下L02细胞和HCC细胞的衰老情况。采用实时逆转录聚合酶链反应、蛋白质免疫印迹分析及免疫组织化学方法,评估Prp19与衰老相关蛋白之间的关系。利用裸鼠皮下异种移植瘤评估Prp19对衰老的作用。数据分析采用GraphPad Prism 6软件。

结果

Prp19促进了不同应激条件下L02细胞和HCC细胞的衰老。Prp19在mRNA水平上正向调节p21的表达。Prp19的下调促进了HCC细胞系产生的皮下异种移植瘤的生长。

结论

Prp19可能通过调节p21的表达促进HCC细胞的衰老。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60af/8959953/fce3f11d199e/JO2022-5705896.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60af/8959953/1388f39699ba/JO2022-5705896.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60af/8959953/dfa9d73a01e3/JO2022-5705896.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60af/8959953/27faa8c9aa7c/JO2022-5705896.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60af/8959953/fce3f11d199e/JO2022-5705896.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60af/8959953/1388f39699ba/JO2022-5705896.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60af/8959953/dfa9d73a01e3/JO2022-5705896.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60af/8959953/27faa8c9aa7c/JO2022-5705896.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60af/8959953/fce3f11d199e/JO2022-5705896.004.jpg

相似文献

1
Prp19 Facilitated p21-Dependent Senescence of Hepatocellular Carcinoma Cells.Prp19促进肝癌细胞中p21依赖的衰老。
J Oncol. 2022 Mar 21;2022:5705896. doi: 10.1155/2022/5705896. eCollection 2022.
2
Prp19 facilitates invasion of hepatocellular carcinoma via p38 mitogen-activated protein kinase/twist1 pathway.Prp19通过p38丝裂原活化蛋白激酶/ Twist1途径促进肝细胞癌的侵袭。
Oncotarget. 2016 Apr 19;7(16):21939-51. doi: 10.18632/oncotarget.7877.
3
Prp19 Arrests Cell Cycle via Cdc5L in Hepatocellular Carcinoma Cells.在肝癌细胞中,Prp19通过Cdc5L阻滞细胞周期。
Int J Mol Sci. 2017 Apr 7;18(4):778. doi: 10.3390/ijms18040778.
4
Increased PRP19 in Hepatocyte Impedes B Cell Function to Promote Hepatocarcinogenesis.肝细胞中PRP19的增加会阻碍B细胞功能,从而促进肝癌发生。
Adv Sci (Weinh). 2024 Dec;11(46):e2407517. doi: 10.1002/advs.202407517. Epub 2024 Oct 18.
5
Pre-mRNA processing factor 19 functions in DNA damage repair and radioresistance by modulating cyclin D1 in hepatocellular carcinoma.前体mRNA加工因子19通过调节肝细胞癌中的细胞周期蛋白D1在DNA损伤修复和放射抗性中发挥作用。
Mol Ther Nucleic Acids. 2021 Dec 9;27:390-403. doi: 10.1016/j.omtn.2021.12.002. eCollection 2022 Mar 8.
6
Atorvastatin-induced senescence of hepatocellular carcinoma is mediated by downregulation of hTERT through the suppression of the IL-6/STAT3 pathway.阿托伐他汀诱导的肝癌细胞衰老通过抑制IL-6/STAT3信号通路下调hTERT来介导。
Cell Death Discov. 2020 Mar 30;6:17. doi: 10.1038/s41420-020-0252-9. eCollection 2020.
7
circLARP4 induces cellular senescence through regulating miR-761/RUNX3/p53/p21 signaling in hepatocellular carcinoma.环状 LARP4 通过调控 miR-761/RUNX3/p53/p21 信号通路诱导肝癌细胞衰老。
Cancer Sci. 2019 Feb;110(2):568-581. doi: 10.1111/cas.13901. Epub 2019 Jan 4.
8
Suppression of AGTR1 Induces Cellular Senescence in Hepatocellular Carcinoma Through Inactivating ERK Signaling.抑制AGTR1通过使ERK信号失活诱导肝癌细胞衰老。
Front Bioeng Biotechnol. 2022 Jul 13;10:929979. doi: 10.3389/fbioe.2022.929979. eCollection 2022.
9
DNA damage induces down-regulation of Prp19 via impairing Prp19 stability in hepatocellular carcinoma cells.DNA损伤通过损害肝癌细胞中Prp19的稳定性诱导Prp19下调。
PLoS One. 2014 Feb 28;9(2):e89976. doi: 10.1371/journal.pone.0089976. eCollection 2014.
10
The hepatic senescence-associated secretory phenotype promotes hepatocarcinogenesis through Bcl3-dependent activation of macrophages.肝脏衰老相关分泌表型通过Bcl3依赖性激活巨噬细胞促进肝癌发生。
Cell Biosci. 2021 Sep 16;11(1):173. doi: 10.1186/s13578-021-00683-5.

引用本文的文献

1
Increased PRP19 in Hepatocyte Impedes B Cell Function to Promote Hepatocarcinogenesis.肝细胞中PRP19的增加会阻碍B细胞功能,从而促进肝癌发生。
Adv Sci (Weinh). 2024 Dec;11(46):e2407517. doi: 10.1002/advs.202407517. Epub 2024 Oct 18.
2
PRPF19 modulates morphology and growth behavior in a cell culture model of human skin.PRPF19在人皮肤细胞培养模型中调节细胞形态和生长行为。
Front Aging. 2023 May 5;4:1154005. doi: 10.3389/fragi.2023.1154005. eCollection 2023.

本文引用的文献

1
Molecular therapies for HCC: Looking outside the box.肝细胞癌的分子疗法:跳出框框思考。
J Hepatol. 2020 Feb;72(2):342-352. doi: 10.1016/j.jhep.2019.09.010.
2
International trends in hepatocellular carcinoma incidence, 1978-2012.国际 1978-2012 年肝细胞癌发病率趋势。
Int J Cancer. 2020 Jul 15;147(2):317-330. doi: 10.1002/ijc.32723. Epub 2019 Nov 5.
3
Inducing and exploiting vulnerabilities for the treatment of liver cancer.诱导和利用肝癌治疗中的脆弱性。
Nature. 2019 Oct;574(7777):268-272. doi: 10.1038/s41586-019-1607-3. Epub 2019 Oct 2.
4
The role of telomeres and telomerase in cirrhosis and liver cancer.端粒和端粒酶在肝硬化和肝癌中的作用。
Nat Rev Gastroenterol Hepatol. 2019 Sep;16(9):544-558. doi: 10.1038/s41575-019-0165-3. Epub 2019 Jun 28.
5
Depletion of TRRAP Induces p53-Independent Senescence in Liver Cancer by Down-Regulating Mitotic Genes.TRRAP 耗竭通过下调有丝分裂基因诱导肝癌中的 p53 非依赖性衰老。
Hepatology. 2020 Jan;71(1):275-290. doi: 10.1002/hep.30807. Epub 2019 Aug 11.
6
circLARP4 induces cellular senescence through regulating miR-761/RUNX3/p53/p21 signaling in hepatocellular carcinoma.环状 LARP4 通过调控 miR-761/RUNX3/p53/p21 信号通路诱导肝癌细胞衰老。
Cancer Sci. 2019 Feb;110(2):568-581. doi: 10.1111/cas.13901. Epub 2019 Jan 4.
7
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
8
miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer.miR-191/DAB2 轴调控雌激素受体阳性乳腺癌的致瘤性。
IUBMB Life. 2018 Jan;70(1):71-80. doi: 10.1002/iub.1705. Epub 2017 Dec 16.
9
Prp19 Arrests Cell Cycle via Cdc5L in Hepatocellular Carcinoma Cells.在肝癌细胞中,Prp19通过Cdc5L阻滞细胞周期。
Int J Mol Sci. 2017 Apr 7;18(4):778. doi: 10.3390/ijms18040778.
10
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression.衰老相关免疫反应在肝脏肿瘤监测与肿瘤进展中的不同功能
Cancer Cell. 2016 Oct 10;30(4):533-547. doi: 10.1016/j.ccell.2016.09.003.